⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Mahindra Lifespace Developers LimitedMAHLIFE

Mahindra Lifespace Developers Limited is an Indian real estate developer focused on healthcare infrastructure.

Key productsHealthcare infrastructure projects
GeographyIndia, with a focus on major cities
CompetitorsDLF Limited, Jaypee Group

AI-generated overview — verify before relying on it.

Net institutional flow

27.9 Cr

Institutional buyers

0 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Rs 3.50 Per Share

ex 2026-07-03

Competitive landscape — the read

vs most-traded names · 2Y
Institutional money is backing MTNL hardest (+41.3 Cr net). MAHLIFE ranks #6 of 7 on flow (net selling 27.9 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1MTNL+41.3 Cr331
2ATALREAL+7 Cr367
3GATECH+0.4 Cr298
4IRMENERGY2.2 Cr356
5QUADFUTURE9 Cr581
6MAHLIFEThis27.9 Cr3
7MOBIKWIK150.9 Cr975

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — MAHLIFE day by day

  1. 2026-07-03ActionDividend - Rs 3.50 Per ShareDividend
  2. 2025-07-18ActionDividend - Rs 2.80 Per ShDividend
  3. 2025-05-23ActionRights 3:8 @ Premium Rs 247/-Rights
  4. 2025-03-19BulkSELL · ₹27.9 CrGOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO
  5. 2025-03-19BulkBUY · ₹36.4 CrGRAVITON RESEARCH CAPITAL LLP
  6. 2025-03-19BulkSELL · ₹36.4 CrGRAVITON RESEARCH CAPITAL LLP
  7. 2025-03-19NetDay net −₹27.9 Cr
  8. 2024-07-12ActionDividend - Rs 2.65 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for MAHLIFE yet.

Bulk & block deals

3 deals · 2025-03-19 → 2025-03-19

DateCounterpartyTypeSideValue
2025-03-19GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIOInstitutionSELL₹27.9 Cr
2025-03-19GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹36.4 Cr
2025-03-19GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹36.4 Cr

3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on MAHLIFE

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.